课题基金 / 基金详情

STRUCTURE FUNCTION STUDY OF MT3 TOXIN

STRUCTURE FUNCTION STUDY OF MT3 TOXIN
MT3毒素的结构功能研究
批准号:
7073018
负责人:
KRISHNA BAKSI
金额:
$18.52万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-01 至 2010-03-31

项目摘要

项目成果

KRISHNA BAKSI的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):毒蕈碱乙酰胆碱受体(mAChR)与G蛋白偶联,并激活不同的第二信使和离子通道。目前,mAChR有五种亚型(MrM 5),并且在整个身体中分布不同。mAChR涉及多种疾病,例如精神分裂症、帕金森病(PD)、阿尔茨海默病(AD)、心律失常、青光眼、肠易激综合征和哮喘。无论技术的发展,mAChR亚型的功能和表征的研究一直落后,由于缺乏高选择性的激动剂和拮抗剂。识别mAChR的几种毒素已经从树眼镜蛇属的曼巴蛇的毒液中纯化并测序。毒素的序列是同源的,但它们的作用模式和对mAChR亚型的选择性是不同的。例如,MT3毒素对M4受体显示出较高的亲和力,而对M4受体显示出较低的亲和力。然而,MT 7特异于IV 1受体。MT3毒素的结构-功能关系对于确定与M4受体结合的关键氨基酸残基是必不可少的。MT3毒素的合成基因和表达系统在我的实验室可用于此类研究。该建议的假设是MT3毒素的功能位点需要多个氨基酸残基,这些氨基酸残基存在于毒素的所有三个环中,用于其亚型特异性以及用于其作为拮抗剂的作用。因此,我提出研究MT3毒素的结构-功能关系,我的建议的具体目标是:具体目标1:MT3/MT 7嵌合体和MT3类似物的生产:这将通过以下实验来实现:(i)合成MT3毒素基因,并使用pPICZaA表达载体在毕赤酵母中表达MT3毒素,并通过标准方法纯化;(ii)MT3/MT 7嵌合体和MT3类似物的产生;和(iii)MT3/MT 7嵌合体和MT3类似物的结构-功能。使用[3 H]-NMS结合试验筛选嵌合体/类似物与CHO细胞中单独表达的M1-M5受体的结合。特定目的2:MT3毒素类似物与其受体的相互作用模式。使用表达M4受体的CHO细胞,对M4受体具有更高选择性的MT3类似物进行激动剂/拮抗剂/变构相互作用。本研究的完成将确定负责MT3毒素亚型特异性的特定氨基酸残基。该提案的长期目标是设计和开发基于三维模板的治疗剂,在该三维模板上可以针对涉及mAChR的不同疾病设计较小的分子模拟物。
英文摘要
DESCRIPTION (provided by applicant): Muscarinic acetylcholine receptors (mAChRs) are coupled to G-proteins and activate different second messengers and ion channels. Currently, there are five subtypes of mAChRs (MrM5), and are differentially distributed throughout the body. mAChRs are involved in a variety of disorders such as Schizophrenia, Parkinson's disease (PD), Alzheimer's disease (AD), cardiac arrhythmia, glaucoma, irritable bowel syndrome and asthma. Irrespective of the technological developments, the study of functions and characterization of mAChR subtypes has been lagging behind due to lack of highly selective agonists and antagonists. Several toxins which recognize the mAChRs have been purified and sequenced from the venom of mamba snakes of the genus Dendroaspis. The sequences of the toxins are homologous, but their mode of action and selectivity for mAChR subtypes are different. For example, MT3 toxin shows higher affinity for M4 receptors, and lower affinity for M! receptors, whereas, MT7 is specific for Iv^ receptors. The structure-function relationship of MT3 toxin is essential to establish the critical amino acid residues for the binding to the M4 receptors. Synthetic gene for MT3 toxin and the expression system are available in my laboratory for such studies. The hypothesis of this proposal is that the functional site of MT3 toxin requires multiple amino acid residues which are present in all the three loops of the toxin for its subtype specificity as well as for its action as an antagonist. I, therefore, propose to study the structure-function relationship of MT3 toxin, and the specific aims of my proposal are: SPECIFIC AIM 1: Production of MT3/MT7 chimeras and MT3 analogues: This will be achieved by the following experiments: (i) Synthesis MT3 toxin gene, and expression of MT3 toxin in Pichia pastoris using pPICZaA expression vector, and will be purified by the standard methods; (ii) Production of MT3/MT7 chimeras and MT3 analogue; and (iii) The structure-function of MT3/MT7 chimeras and MT3 analogues. The chimeras/analogues will be screened for their binding to Mi-M5 receptors expressed individually in CHO cells using [3H]-NMS binding assay. SPECIFIC AIM 2: The mode of interactions of MT3 toxin analogues with its receptors. MT3 analogues with higher selectivity for M4 receptors will be subjected for the agonist/antagonist/allosteric interactions using CHO cells expressing M4 receptors. The completion of this study will establish the specific amino acid residues responsible for MT3 toxin's subtype specificity. The long-term goal of this proposal is to design, and to develop therapeutic agents based on the three-dimensional template on which smaller molecule mimics can be designed for different disorders involving mAChRs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PROTEIN & NUCLEIC ACID CORE FACILITY
  • 批准号:
    8357096
  • 项目类别:
  • 资助金额:
    $8.44万
  • 财政年份:
    2011
  • 负责人:
    KRISHNA BAKSI
  • 依托单位:
PROTEIN & NUCLEIC ACID CORE FACILITY
  • 批准号:
    8166200
  • 项目类别:
  • 资助金额:
    $12.01万
  • 财政年份:
    2010
  • 负责人:
    KRISHNA BAKSI
  • 依托单位:
PROTEIN & NUCLEIC ACID CORE FACILITY
  • 批准号:
    7959231
  • 项目类别:
  • 资助金额:
    $12.77万
  • 财政年份:
    2009
  • 负责人:
    KRISHNA BAKSI
  • 依托单位:
PROTEIN & NUCLEIC ACID CORE FACILITY
  • 批准号:
    7715321
  • 项目类别:
  • 资助金额:
    $13.48万
  • 财政年份:
    2008
  • 负责人:
    KRISHNA BAKSI
  • 依托单位:
海外基金